Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends


Award-winning journal providing in-depth analysis on today’s most important topics

Out of Stock: Medical Supply Chain Shortages Impacting Workers’ Comp

Ancillary medical product and service shortages and how to manage them.

Social Influencers: The Role of Social Determinants of Health in Injured Worker Recovery

Gaining visibility into Social Determinants of Health that intersect with workplace injury and recovery

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.
May 2022

Silvia Sacalis to Join Panel Presentation at PRIMA 2022

Healthe’s VP of Clinical Services will join a discussion on post-COVID lessons for workers’ comp.
May 2022

Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.
Apr 2022

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020
1 2 3 4